Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2005
08/25/2005US20050187260 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants
08/25/2005US20050187252 Novel compounds as opioid receptor modulators
08/25/2005US20050187242 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
08/25/2005US20050187237 Therapeutic compounds and uses thereof
08/25/2005US20050187218 Imidazole based kinase inhibitors
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050186263 PH-sensitive polymeric micelles for drug delivery
08/25/2005CA2556239A1 Vanilloid receptor ligands and their use in treatments
08/25/2005CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2554465A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2536622A1 Inhibitors of cellular necrosis
08/24/2005EP1565461A2 Antibacterial substituted cyanomethyl(ene)piperidinophenyl oxazolidinones, process for their preparation, and pharmaceutical compositions containing them
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1565187A2 Methods of treating cancer and related methods
08/24/2005EP1565186A1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/24/2005EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659268A Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1657524A Substituted azole compounds and their preparation and application
08/24/2005CN1657523A Cyclic compounds
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/23/2005US6933393 Reacting methyl cyanoacetate with morphiline to form 3-morpholin-4-yl-3-oxo- propionitrile; forming salt; reacting with phenylacetic acid and 2-(2-(4-fluorophenyl)-2-oxo-1-phenyl-ethyl)-4-
08/23/2005US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005CA2469592C Hiv integrase inhibitors
08/23/2005CA2064373C Piperidine derivatives
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005075467A2 Crystalline forms of zolmitriptan
08/18/2005WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005075424A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/18/2005WO2005063742A3 Amidino compounds as cysteine protease inhibitors
08/18/2005WO2005058888A3 Oxazolidinone-quinolone hybrid antibiotics
08/18/2005WO2005040345A3 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
08/18/2005WO2005013909A3 Novel cathepsin k inhibitors
08/18/2005WO2004100873A3 Compounds, compositions, and methods
08/18/2005WO2004062361A3 Spiro compounds
08/18/2005US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/18/2005US20050182116 Such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/18/2005US20050182113 Method for preparing diaryl-substituted isoxazole compounds
08/18/2005US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus
08/18/2005US20050182095 Piperdine derivatives useful as CCR3 antagonists
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182067 Vanilloid receptor ligands and their use in treatments
08/18/2005US20050182061 Phthalimide compounds useful as protein kinase inhibitors
08/18/2005US20050182055 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide formed by reacting 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-morpholin-3-one hydrochloride with 5-chlorothiophene-2-carbonyl chloride
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/18/2005DE102004004928A1 Dibenzoxazepine II Dibenzoxazepines II
08/18/2005DE102004004787A1 New effector-linker and effector-recognition unit conjugates derived from epothilones, useful as targeted drugs for treating proliferative diseases, e.g. tumors or neurodegenerative disease
08/18/2005DE102004004731A1 Harnstoffderivate Urea derivatives
08/18/2005DE102004002885A1 New pyrrole alkaloid daminin and its derivatives, are intracellular calcium ion concentration reducing neuroprotective agents useful for treating neurodegenerative diseases, e.g. Alzheimer's disease
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/18/2005CA2553604A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/17/2005EP1563300A2 Diagnostic method for celiac sprue
08/17/2005EP1562941A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
08/17/2005EP1562940A2 Aryl sulfonamides
08/17/2005EP1562939A1 Carboxamides
08/17/2005EP1562938A1 Heteroaryl-pyrimidine derivatives as jak inhibitors
08/17/2005EP1562937A2 N-substituted piperidine derivatives as serotonin receptor agents
08/17/2005EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/17/2005EP1562918A1 Substituted benzoxazinones and uses thereof
08/17/2005EP1562917A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
08/17/2005EP1562915A1 Farnesoid x receptor agonists
08/17/2005EP1562907A1 Pyridine derivatives as cb2 receptor modulators
08/17/2005EP1562902A1 2-pyridone derivatives as inhibitors of neutrophile elastase
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1562595A1 Diaryl ethers as opioid receptor antagonists
08/17/2005EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases
08/17/2005EP1343761B1 Piperidine mch antagonists and their use in the treatment of obesity
08/17/2005EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1656089A Phenyl-thiophene type vitamin D receptor modulators
08/17/2005CN1656083A Novel heterocyclic compounds having antibacterial activity; process for their preparation and pharmaceutical compositions containing them
08/17/2005CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
1 ... 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 ... 647